Physician incentives may not boost diabetes care | Experts study costs of lower A1C cutoffs in type 2 diabetes | Study: Thiazolidinediones curb cancer risk in diabetes
April 27, 2012
DiabetesPro SmartBrief
News for diabetes health professionals
Diabetes in Focus
Physician incentives may not boost diabetes care
Despite a physician incentive program in Canada that promotes routine exams for diabetes patients, only 37% of patients got the recommended number of blood glucose tests and only 59% had the recommended cholesterol tests between 2006 and 2008, according to a study in Diabetes Care. The lead researcher said some doctors may not have been aware of the incentive program or may not have thought it was worth the effort.
Reuters (4/26) 
Experts study costs of lower A1C cutoffs in type 2 diabetes
Lowering the A1C cutoff from 6.0% to 5.9% in type 2 diabetes patients who were on a high-cost intervention would cost $27,000 per quality-adjusted life-year gained and lowering it from 5.9% to 5.8% would cost $34,000 per QALY gained, a study indicated. Researchers also said the cost of lowering the cutoff from 6.0% to 5.9% in patients on a low-cost intervention would cost $24,000 per QALY gained and lowering it from 5.9% to 5.8% would cost $27,000 per QALY gained. The results were published in the American Journal of Preventive Medicine.
Family Practice News (4/23) 
LinkedIn Twitter Facebook Google+ Email
Study: Thiazolidinediones curb cancer risk in diabetes
Data on 606,583 adult type 2 diabetes patients without a history of cancer revealed those who received thiazolidinediones were less likely to develop liver and colorectal cancers than their counterparts who did not take the drugs. Higher cumulative dosages and longer treatment duration were associated with stronger cancer protection in patients who were on the medications, researchers reported in Hepatology.
Physician's Briefing/HealthDay News/HealthDay News (4/26) 
LinkedIn Twitter Facebook Google+ Email
Ranibizumab improves vision in patients with diabetic macular edema
A study in Ophthalmology revealed more patients with diabetic macular edema who took ranibizumab attained better visual acuity and showed vision improvements than those who had sham treatments. Researchers also noted fewer cases of vision loss in the ranibizumab group compared with the sham treatment group.
Medscape (free registration) (4/26) 
LinkedIn Twitter Facebook Google+ Email
Nutrition & Wellness
Study: White-potato intake doesn't trigger obesity or diabetes
Researchers at the University of Washington found that frequent intake of white potatoes is not linked to the onset of obesity or type 2 diabetes or to a higher C-reactive protein level when demographic factors are taken into account. The study was reported at the Federation of American Societies for Experimental Biology Conference.
Yahoo!/Asian News International (4/26) 
LinkedIn Twitter Facebook Google+ Email
Changing gut bacteria may help address obesity
French researchers found that mice that received gut bacteria from obesity-prone rats consumed more food, put on more weight and were more obese compared with their counterparts that got the bacteria from obesity-resistant rats. The results, presented at an American Society for Nutrition meeting, suggest altering intestinal bacteria may help reduce the risk of obesity.
NutraIngredients (4/26) 
LinkedIn Twitter Facebook Google+ Email
Rapid weight gain in young children linked to later hypertension
An Australian study of children from birth to age 14 showed the top 32% with the fastest weight gain had high blood pressure that could be detected as early as age 3. Reducing childhood obesity and early fat gain could curb levels of metabolic conditions, such as diabetes and hypertension, the lead researcher said. The findings were presented at the European Society of Hypertension conference.
United Press International (4/26) 
LinkedIn Twitter Facebook Google+ Email
Practice Update
Study: Discrepancy exists in doctors' intention, readiness to meet MU
There is a disparity between the intentions of doctors to receive meaningful use payments and their preparedness to achieve even two-thirds of the key requirements, according to the authors of a study in Health Affairs. The study, which included a survey of 3,996 doctors in 2011 and was conducted by a team of researchers led by Chun-Ju Hsiao, indicated that 91% of doctors nationwide believed they qualify for Medicare or Medicaid incentives, while only 10% aimed to apply for the MU initiative.
Healthcare IT News (4/25) 
LinkedIn Twitter Facebook Google+ Email
Small providers continue to lag in EHR use, research finds
A pair of studies in Health Affairs indicated small, rural hospitals and physician practices still fall behind large, urban facilities in implementing EHRs. The researchers recommended the federal government continue to provide incentives and assistance to smaller practices and step up efforts to help slow adopters deploy EHRs.
Modern Healthcare (subscription required) (4/25) 
LinkedIn Twitter Facebook Google+ Email
Trends & Technology
Report: Physician adoption of Web-based EMRs grows
A Kalorama Information report revealed that EMR sales to doctors rose about 22% between 2010 and 2011, higher than the growth rate of EMR sales to hospital systems. The report also noted that doctors are particularly drawn to Web-based systems sold over the Internet, making it the fastest-growing segment of the EMR market.
Healthcare Informatics online (4/25), (4/26) 
LinkedIn Twitter Facebook Google+ Email
Ideas are like rabbits. You get a couple and learn how to handle them, and pretty soon you have a dozen.
John Steinbeck,
American writer
LinkedIn Twitter Facebook Google+ Email
Learn more about DiabetesPro:
DiabetesPro Home | Professional Education | Journals
Research Grants | Recognition Programs | Membership
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information